Research output per year
Research output per year
Search results
-
2022
Author Correction: A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma
Kjeldsen, J. W., Lorentzen, C. L., Martinenaite, E., Ellebaek, E., Donia, M., Holmstroem, R. B., Klausen, T. W., Madsen, C. O., Ahmed, S. M., Weis-Banke, S. E., Holmström, M. O., Hendel, H. W., Ehrnrooth, E., Zocca, M-B., Pedersen, A. W., Andersen, M. H. & Svane, I. M., Apr 2022, 1 p.Research output: Other contribution › Research
1 Citation (Scopus) -
2021
A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma
Kjeldsen, J. W., Lorentzen, C. L., Martinenaite, E., Ellebaek, E., Donia, M., Holmstroem, R. B., Klausen, T. W., Madsen, C. O., Ahmed, S. M., Weis-Banke, S. E., Holmström, M. O., Hendel, H. W., Ehrnrooth, E., Zocca, M. B., Pedersen, A. W., Andersen, M. H. & Svane, I. M., Dec 2021, In: Nature Medicine. 27, 12, p. 2212-2223 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
63 Citations (Scopus)